SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-23-000214
Filing Date
2023-01-06
Accepted
2023-01-06 08:30:29
Documents
12
Period of Report
2022-12-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K 12212022 alks-8k_20221221.htm   iXBRL 8-K 36022
  Complete submission text file 0001564590-23-000214.txt   164089

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alks-20221221.xsd EX-101.SCH 5589
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20221221_lab.xml EX-101.LAB 19265
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20221221_pre.xml EX-101.PRE 11466
6 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20221221_htm.xml XML 3525
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 23513803
SIC: 2834 Pharmaceutical Preparations